Premium
P1‐116: NEUROFILAMENT LIGHT LEVELS IN THE CEREBROSPINAL FLUID ARE UNCOUPLED OF AMYLOIDOSIS IN LATE STAGE PATHOGENESIS OF APP TRANSGENIC MICE
Author(s) -
Droege Ruth E.,
Kaeser Stephan A.,
Schelle Juliane,
Haesler Lisa M.,
Al-Shaana Rawaa,
Rother Christine,
Neumann Ulf,
Shimshek Derya R.,
Staufenbiel Matthias,
Jucker Mathias
Publication year - 2018
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2018.06.119
Subject(s) - cerebrospinal fluid , genetically modified mouse , pathogenesis , transgene , amyloid precursor protein , neurodegeneration , amyloidosis , amyloid (mycology) , neurofilament , endocrinology , medicine , alzheimer's disease , biomarker , chemistry , pathology , disease , immunohistochemistry , biochemistry , gene
P1-115 INVIVO PROPAGATIONOFSYNTHETICAb CONFORMATIONAL STRAINS Rodrigo Morales, Carlos Kramm-Barria, Ruben GomezGutierrez, Robert Tycko, Claudio Soto, The University of Texas Health Science Center at Houston, Houston, TX, USA; Dept. Neurology, The University of Texas Health Science Center at Houston, Houston, TX, USA; National Institutes of Health, Bethesda, MD, USA. Contact e-mail: rodrigo.moralesloyola@uth. tmc.edu